Cited2 protein level in cumulus cells is a biomarker for human embryo quality and pregnancy outcome in one in vitro fertilization cycle  Yuan Fang, Ph.D.,

Slides:



Advertisements
Similar presentations
Expression of the novel gene embryo implantation factor 2 (EMO2) in the mouse uterus at the implantation sites  Zhaogui Sun, Ph.D., Renwei Su, Ph.D.,
Advertisements

A time to look back: analysis of morphokinetic characteristics of human embryo development  Javier Herrero, Ph.D., Alberto Tejera, Ph.D., Carmela Albert,
Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 
Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion    Fertility and Sterility 
Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate  Jesus Aguilar, Ph.D., Irene Rubio, Ph.D., Elkin.
Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome  Li Chen, M.S., Wen.
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
MicroRNAs in spent blastocyst culture medium are derived from trophectoderm cells and can be explored for human embryo reproductive competence assessment 
Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 
Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication  Thamara Viloria,
Progesterone regulation of glutathione S-transferase Mu2 expression in mouse uterine luminal epithelium during preimplantation period  Hua Ni, Ph.D.,
Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.
No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.
Agnieszka Malcher, M. S. , Natalia Rozwadowska, Ph. D
Apoptosis-inhibitor Aven is downregulated in defective spermatogenesis and a novel estrogen target gene in mammalian testis  Sandra Laurentino, B.Sc.,
Yu Wang, M. D. , Ph. D. , Yang Lv, Ph. D. , Liyan Wang, M. D
Sperm DNA damage measured by the alkaline Comet assay as an independent predictor of male infertility and in vitro fertilization success  Luke Simon,
Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph
Ovarian pregnancy after in vitro fertilization
Pei-Tzu Li, M. S. , Chi-Jr Liao, M. S. , Wen-Guey Wu, Ph. D
Expression and localization of transcription factor Ets-1 in the rat ovary during the estrous cycle and pregnancy  Xiaohui Xiao, M.S., Aiqin Liu, Ph.D.,
Guoying Dong, B. S. , Yueshuai Guo, B. S. , Huarong Cao, B. S
Zhen Tian, Ph. D. , Zhen-Ao Zhao, Ph. D. , Xiao-Huan Liang, Ph. D
Down-regulation of DJ-1 protein in the ejaculated spermatozoa from Chinese asthenozoospermia patients  Chun-Na An, M.S., Hui Jiang, M.D., Qi Wang, M.S.,
Regulation of myeloid ecotropic viral integration site 1 and its expression in normal and abnormal endometrium  Linli Hu, M.D., Haixia Li, M.D., CindyTzu-Ling.
Live birth of twins derived from zona-free oocytes
Ali Sazci, Ph. D. , Nesrin Ercelen, M. D. , Emel Ergul, M. S
Immunization with a DNA vaccine of testis-specific sodium-hydrogen exchanger by oral feeding or nasal instillation reduces fertility in female mice  Tao.
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
FSH receptor, KL1/2, P450, and PAPP genes in granulosa-lutein cells from in vitro fertilization patients show a different expression pattern depending.
Administration of visfatin during superovulation improves developmental competency of oocytes and fertility potential in aged female mice  Kyoung-Hwa.
Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order.
Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and.
Estrogenic regulation of testicular expression of stem cell factor and c-kit: implications in germ cell survival and male fertility  Sara Correia, M.S.,
Embryo incubation and selection in a time-lapse monitoring system improves pregnancy outcome compared with a standard incubator: a retrospective cohort.
Expression of the novel gene embryo implantation factor 2 (EMO2) in the mouse uterus at the implantation sites  Zhaogui Sun, Ph.D., Renwei Su, Ph.D.,
Time-lapse deselection model for human day 3 in vitro fertilization embryos: the combination of qualitative and quantitative measures of embryo growth 
Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis  Cui Hong Zheng, M.D., Ph.D.,
Yan Wen, M. D. , Rudy Quintero, M. D. , Bertha Chen, M. D
Eszter Ducza, Ph. D. , Róbert Gáspár, Ph. D. , Attila Mihályi, Ph. D
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and.
Hong-Lu Diao, Ph. D. , Ren-Wei Su, B. S. , Hui-Ning Tan, Ph. D
JunWei Qu, M. D. , Yong Wang, Ph. D. , Xiaoke Wu, M. D. , Ph. D
The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive.
Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms  Anastasia Tsigkou,
What are patients doing with their mosaic embryos
Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: a comparison of pregnant and obese women  Suman Rice, Ph.D., Bijal Patel,
Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a.
Prediction of pregnancy rate by blastocyst morphological score and age, based on 1,488 single frozen-thawed blastocyst transfer cycles  Sakae Goto, M.D.,
Granulosa–lutein cell growth differentiation factor-9 (GDF-9) messenger RNA and protein expression in in vitro fertilization (IVF) cycles: relation to.
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Stephanie L. F. Gustin, M. D. , Gourab Mukherjee, Valerie L. Baker, M
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
Mitochondrial gene expression in granulosa cells of severe endometriosis with in vitro fertilization and embryo transfer  Yoshiki Yamashita, M.D., Masako.
José Bellver, M. D. , Yanira Ayllón, M. D. , Marcos Ferrando, M. D
Autophagy is upregulated in ovarian endometriosis: a possible interplay with p53 and heme oxygenase-1  Giulia Allavena, M.S., Patrizia Carrarelli, Ph.D.,
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Circulating microRNAs as potential biomarkers for endometriosis
Sperm deoxyribonucleic acid fragmentation as a prognostic indicator of assisted reproductive technology outcome  Mehdi Benchaib, M.D., Ph.D., Jacqueline.
An investigation into the relationship between the metabolic profile of follicular fluid, oocyte developmental potential, and implantation outcome  Martina.
Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B
Genetic evaluation procedures at sperm banks in the United States
Susanna McReynolds, Ph. D. , Monika Dzieciatkowska, Ph. D
Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery.
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulosa cells?  Masako Karita, M.D., Yoshiki.
Altered circulating levels of matrix metalloproteinases 2 and 9 and their inhibitors and effect of progesterone supplementation in women with endometriosis.
Adrienne B. Neithardt, M. D. , James H. Segars, M. D
A time to look back: analysis of morphokinetic characteristics of human embryo development  Javier Herrero, Ph.D., Alberto Tejera, Ph.D., Carmela Albert,
Presentation transcript:

Cited2 protein level in cumulus cells is a biomarker for human embryo quality and pregnancy outcome in one in vitro fertilization cycle  Yuan Fang, Ph.D., Wei Shang, M.M., De-Li Wei, M.S., Shen-Ming Zeng, Ph.D.  Fertility and Sterility  Volume 105, Issue 5, Pages 1351-1359.e4 (May 2016) DOI: 10.1016/j.fertnstert.2015.12.137 Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Association of Cited2 levels in CCs with embryo development potential. HC = high Cited2 group; LC = low Cited2 group. Association of Cited2 levels in CCs with embryo development potential from (A) IVF and (B) ICSI patients. Embryos that could be used for transplantation (grades 1 and 2) were estimated on day 3 after insemination according to the grading system described in Materials and Methods (grades 1–4). Association of the Cited2 levels in CCs with pregnancy outcome in (C) IVF and (D) ICSI patients. A comparison of the outcome of implantation and pregnancy rates in both the study and control groups was performed using the χ2 test. (E) Mean of Cited2/β-actin levels in pregnant and nonpregnant IVF patients. (F) Mean of Cited2/β-actin levels in pregnant and nonpregnant ICSI patients. Bars with different letters (a, b) are significantly different (P<.05). Fertility and Sterility 2016 105, 1351-1359.e4DOI: (10.1016/j.fertnstert.2015.12.137) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Association of infertility factors with the expression of Cited2 protein in human CCs. A total of 72 patients were examined. HC = high Cited2 group; LC = low Cited2 group. UI = unexplained infertility (unexplained causes of infertility from male or female except the following factors; n = 19): TF (n = 22); male factor (MF) (n = 11); endometriosis (E) (n = 2); hypo-ovarianism (H) (n = 4); PCOS (n = 14). The rest of the patients (n = 9) had various known causes of infertility and therefore did not participate in statistics. The proportions of PCOS (and TF) in the high and low Cited2 patients were statistically compared by χ2 test. (A) Effect of different infertility factors on the distribution of patients in the high and low Cited2 level groups. AFF = all female factors except PCOS and TF (n = 9). (B) Effects of different infertility factors on the levels of Cited2 in human CCs. Bars with different letters (a, b) are significantly different (P<.05). Fertility and Sterility 2016 105, 1351-1359.e4DOI: (10.1016/j.fertnstert.2015.12.137) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Relationship between Cited2 levels and the levels of its related gene and proteins in CCs. HC = high Cited2 group; LC: low Cited2 group. (A, C) Correlation analysis between CL-caspase-3 and Cited2 protein levels in CCs derived from IVF patients. (B, D) Correlation analysis between p53 and Cited2 protein levels in CCs derived from IVF patients. (E) The mRNA expression levels (relative to internal control β-actin; these data were also corrected by GAPDH) of PR and PCK1 in patients with different Cited2 levels. Data are presented relative to the values in the LC groups. (F) Glucose levels in patients with high and low Cited2 levels are shown relative to total protein release in cell lysate. Bars with different letters (a, b) are significantly different (P<.05). Fertility and Sterility 2016 105, 1351-1359.e4DOI: (10.1016/j.fertnstert.2015.12.137) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 Detection of Cited2 protein in human CCs using Western blotting. (A) A representative blot showing Cited2 protein levels in cells obtained from different patients. (B) Quantification of Cited2 protein level in CCs from different patients and positive sample using β-actin as an internal control. On the basis of the results of the assay, patients were divided into two groups (red line) according to the levels of the Cited2/β-actin ratio detected in the CCs from each individual patient. 1–9 indicate different patients; P = positive standard sample. Fertility and Sterility 2016 105, 1351-1359.e4DOI: (10.1016/j.fertnstert.2015.12.137) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 2 Relationship between Cited2 levels and its related gene levels. HC = high Cited2 group; LC = low Cited2 group. The mRNA expression levels (relative to internal control β-actin) of StAR, CYP11A1, CYP19A1, PPARγ, PGC-1α, and GLUT1 in patients with different Cited2 levels were determined using qPCR. Data are presented relative to the values in the LC groups. Bars with different letters (a, b) are significantly different (P<.05). Fertility and Sterility 2016 105, 1351-1359.e4DOI: (10.1016/j.fertnstert.2015.12.137) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 3 Relationship between pregnancy outcome and related factors of Cited2. (A) The CL-caspsase-3 levels (relative to internal control β-actin) in patients with different pregnancy outcomes. (B) The mRNA expression levels (relative to β-actin) of PCK1 in patients with different pregnancy outcomes. Data are presented relative to the values in the pregnant groups. (C) Pregnant outcomes from patients with different glucose levels in CCs. The pregnancy rates between high and glucose level patients were statistically compared by χ2 test. LG = low glucose group; HG = high glucose group. Bars with different letters (a, b) are significantly different (P<.05). Fertility and Sterility 2016 105, 1351-1359.e4DOI: (10.1016/j.fertnstert.2015.12.137) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions